BAF250a (ARID1A) Combined with HNF-1b, ER and P53 Can Distinguish between Ovarian Clear Cell Carcinoma and Papillary Serous Carcinoma

被引：0
|
作者：
Xiao, W. [1 ]
Awadallah, A. [1 ]
Xin, W. [1 ]
机构：
[1] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA
来源：
MODERN PATHOLOGY | 2012年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1267
引用
收藏
页码：301A / 301A
页数：1
相关论文
共 22 条
  • [1] BAF250a (ARIDIA) Combined with HNF-1b, ER and P53 Can Distinguish between Ovarian Clear Cell Carcinoma and Papillary Serous Carcinoma
    Xiao, W.
    Awadallah, A.
    Xin, W.
    LABORATORY INVESTIGATION, 2012, 92 : 301A - 301A
  • [2] The Clinicopathologic Significance of p53 and BAF250a (ARID1A) Expression in Clear Cell Carcinoma of the Endometrium
    Fadare, O.
    Gwin, K.
    Desouki, M. M.
    Crispens, M. A.
    Jones, H. W., III
    Khabele, D.
    Mohammed, K.
    Liang, S. X.
    Zheng, W.
    Hecht, J. L.
    Parkash, V.
    MODERN PATHOLOGY, 2013, 26 : 273A - 273A
  • [3] The Clinicopathologic Significance of p53 and BAF250a (ARID1A) Expression in Clear Cell Carcinoma of the Endometrium
    Fadare, O.
    Gwin, K.
    Desouki, M. M.
    Crispens, M. A.
    Jones, H. W., III
    Khabele, D.
    Mohammed, K.
    Liang, S. X.
    Zheng, W.
    Hecht, J. L.
    Parkash, V.
    LABORATORY INVESTIGATION, 2013, 93 : 273A - 273A
  • [4] Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma
    Xiao, Wenbin
    Awadallah, Amad
    Xin, Wei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2012, 5 (07): : 642 - 650
  • [5] The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium
    Fadare, Oluwole
    Gwin, Katja
    Desouki, Mohamed M.
    Crispens, Marta A.
    Jones, Howard W., III
    Khabele, Dineo
    Liang, Sharon X.
    Zheng, Wenxin
    Mohammed, Khaled
    Hecht, Jonathan L.
    Parkash, Vinita
    MODERN PATHOLOGY, 2013, 26 (08) : 1101 - 1110
  • [6] BAF250a (ARID1A) Expression in Ovarian Clear Cell Adenocarcinoma with an Adenofibromatous Component
    Nishikimi, K.
    Kiyokawa, T.
    Tate, S.
    Iwamoto, M.
    Kisimoto, T.
    Fugo, K.
    Shozu, M.
    MODERN PATHOLOGY, 2013, 26 : 289A - 290A
  • [7] BAF250a (ARID1A) Expression in Ovarian Clear Cell Adenocarcinoma with an Adenofibromatous Component
    Nishikimi, K.
    Kiyokawa, T.
    Tate, S.
    Iwamoto, M.
    Kisimoto, T.
    Fugo, K.
    Shozu, M.
    LABORATORY INVESTIGATION, 2013, 93 : 289A - 290A
  • [8] Loss of BAF250a (ARID1A) Expression in Endometrial Clear Cell Carcinoma: Assessment of Frequency and Clinicopathologic Implications
    Fadare, O.
    Renshaw, I. L.
    Liang, S. X.
    LABORATORY INVESTIGATION, 2012, 92 : 269A - 269A
  • [9] Loss of BAF250a (ARID1A) Expression in Endometrial Clear Cell Carcinoma: Assessment of Frequency and Clinicopathologic Implications
    Fadare, O.
    Renshaw, I. L.
    Liang, S. X.
    MODERN PATHOLOGY, 2012, 25 : 269A - 269A
  • [10] Loss of BAF250a (ARID1A) Expression Is Associated with Progression of Endometriosis-Related Stage I Ovarian Clear Cell Carcinoma
    Kawabata, Ayako
    Kiyokawa, Takako
    Yanaihara, Nozomu
    Okamoto, Aikou
    LABORATORY INVESTIGATION, 2016, 96 : 290A - 290A
123